1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Ovarian cancer

Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer

Technology appraisal guidance [TA389] Published: 27 April 2016

  • Guidance
  • Tools and resources
  • Information for the public
  • History

Tools and resources

Tools to help you put the guidance into practice.

Do not do

  • Do not do information  

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance